Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1968 Jan;108(1):1–13.

Trophoblastic Tumors of the Uterus—Problems of Methotrexate Therapy

F Deborah Johnson, Edwin M Jacobs, William M Silliphant
PMCID: PMC1503023  PMID: 18730089

Abstract

Nineteen patients with trophoblastic tumors of the uterus were evaluated at the University of California San Francisco Medical Center. Eight patients, admitted before 1956, did not receive chemotherapy; the mortality rate was 87.5 per cent. Ten of the remaining 11 patients were given intermittent, intensive Methotrexate therapy; actinomycin D and vincristine were used in treating two patients in whom resistance to Methotrexate developed. The mortality was 10 per cent. Toxicity was a prominent factor but was completely reversible when chemotherapy was stopped.

None of the patients showed recurrent disease during follow-up evaluation eight months to five years and eight months after therapy was completed.

It is postulated that continuing chemotherapy four to six months after the chorionic gonadotropin titer becomes negative decreases recurrent disease.

Full text

PDF
1

Images in this article

7Figure 1.
on p.7
9Figure 2.
on p.9
11Figure 3.
on p.11
11Figure 3.
on p.11
11Figure 3.
on p.11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUXTON C. L. Management of patients with hydatidiform mole. Ann N Y Acad Sci. 1959 Aug 28;80:121–124. doi: 10.1111/j.1749-6632.1959.tb49198.x. [DOI] [PubMed] [Google Scholar]
  2. CHAN D. P. Chorionepithelioma. A study of 41 cases. Br Med J. 1962 Oct 13;2(5310):953–957. doi: 10.1136/bmj.2.5310.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HERTZ R., LEWIS J., Jr, LIPSETT M. B. Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol. 1961 Sep;82:631–640. doi: 10.1016/0002-9378(61)90283-6. [DOI] [PubMed] [Google Scholar]
  4. HERTZ R., LI M. C., SPENCER D. B. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956 Nov;93(2):361–366. doi: 10.3181/00379727-93-22757. [DOI] [PubMed] [Google Scholar]
  5. HERTZ R., LIPSETT M. B., MOY R. H. Effect of Vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women. Cancer Res. 1960 Aug;20:1050–1053. [PubMed] [Google Scholar]
  6. HERTZ R., ROSS G. T., LIPSETT M. B. Primary chemotherapy of nonmetastatic trophoblastic disease in women. Am J Obstet Gynecol. 1963 Jul 15;86:808–814. doi: 10.1016/s0002-9378(16)35198-5. [DOI] [PubMed] [Google Scholar]
  7. LI M. C., HERTZ R., BERGENSTAL D. M. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med. 1958 Jul 10;259(2):66–74. doi: 10.1056/NEJM195807102590204. [DOI] [PubMed] [Google Scholar]
  8. PARK W. W., LEES J. C. Choriocarcinoma; a general review, with an analysis of 516 cases. AMA Arch Pathol. 1950 Feb;49(2):204–241. [PubMed] [Google Scholar]
  9. ROSS G. T., GOLDSTEIN D. P., HERTZ R., LIPSETT M. B., ODELL W. D. SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. Am J Obstet Gynecol. 1965 Sep 15;93:223–229. doi: 10.1016/0002-9378(65)90661-7. [DOI] [PubMed] [Google Scholar]
  10. ROSS G. T., STOLBACH L. L., HERTZ R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res. 1962 Sep;22:1015–1017. [PubMed] [Google Scholar]
  11. THIERSCH J. B. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. Am J Obstet Gynecol. 1952 Jun;63(6):1298–1304. doi: 10.1016/s0002-9378(16)38924-4. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES